Post COVID-19 Market Estimates On NGS-Based RNA-Sequencing Market - Global Forecast to 2025


By Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2025

Date : 2020-11-07

Price Single User:
USD. 1250

Price Multiple User:
USD. 2100

The NGS-Based RNA-Sequencing market, in terms of value, is projected to grow at a CAGR of XX% from 2020 to 2025. The market is estimated to be USD XX Billion in 2019, and is projected to reach XX Billion by 2025. In this study, 2019 has been considered the base year, and 2020 to 2025 the forecast period, for estimating the market size of the global market.




  • To define, describe, and forecast the NGS-Based RNA-Sequencing market in different segmentations
  • To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, and RoW
  • To provide detailed information regarding the major factors influencing the growth of the NGS-Based RNA-Sequencing market (drivers, restraints, opportunities, and industry-specific challenges)
  • To provide a detailed overview of the value chain in the NGS-Based RNA-Sequencing market and analyze the market trends with Porter’s five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the NGS-Based RNA-Sequencing market
  • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global NGS-Based RNA-Sequencing market

1 Introduction  

2 Research Methodology

3 Executive Summary

4 Premium Insights

    4.1 Attractive Opportunities in the NGS-Based RNA-Sequencing Market

    4.2 NGS-Based RNA-Sequencing Market, By Product & Service

    4.3 NGS-Based RNA-Sequencing Market, By Technology

    4.4 NGS-Based RNA-Sequencing Market, By Application

    4.5 NGS-Based RNA-Sequencing Market: By Region


5 Market Overview

    5.1 Introduction

    5.2 Market Dynamics

           5.2.1 Drivers                  

           5.2.2 Restraint                   

           5.2.3 Opportunities                   

           5.2.4 Challenges     


6 NGS-Based RNA-Sequencing Market, By Product & Service
    6.1 Introduction
    6.2 RNA Sequencing Platforms & Consumables
    6.3 Sample Preparation Products
    6.4 RNA Sequencing Services
    6.5 Data Analysis, Storage & Management

7 NGS-Based RNA-Sequencing Market, By Technology
   7.1 Introduction
    7.2 Sequencing By Synthesis
    7.3 Ion Semiconductor Sequencing
    7.4 Single-Molecule Real-Time Sequencing
    7.5 Nanopore Sequencing

8 NGS-Based RNA-Sequencing Market, By Application
   8.1 Introduction
    8.2 Expression Profiling Analysis
    8.3 Small RNA Sequencing
    8.4 De Novo Transcriptome Assembly
    8.5 Variant Calling & Transcriptome Epigenetics

9 NGS-Based RNA-Sequencing Market, By End User
   9.1 Introduction
    9.2 Research & Academia
    9.3 Hospitals & Clinics
    9.4 Pharmaceutical & Biotechnology Companies
    9.5 Other End Users


10 NGS-Based RNA-Sequencing Market, By Region

     10.1 Introduction

     10.2 North America            

     10.3 Europe        

     10.4 Asia Pacific

     10.5 South America

     10.6 Rest of the World (RoW)


11 Competitive Landscape


12 Company Profiles

     12.1 Agilent Technologies

     12.2 BGI Group

     12.3 Eurofins Scientific

     12.4 GENEWIZ (Part of Brooks Automation)

     12.5 Hamilton Company

     12.6 Illumina

     12.7 Nugen Technologies (Part of Tecan Trading AG)

     12.8 Oxford Nanopore Technologies

     12.9 Perkinelmer

     12.10 Psomagen

     12.11 QIAGEN

     12.12 F. Hoffmann-La Roche AG

     12.13 Takara Bio

     12.14 Thermo Fisher Scientific

     12.15 Zymo Research



The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing market, by application, in 2018

Based on application, the NGS-based RNA sequencing market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share of the NGS-based RNA sequencing market. The dominant market position of this segment is attributed mainly to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. These factors will continue to propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

The nanopore segment is expected to register the highest growth in the NGS-based RNA-sequencing market, by type, during the forecast period

Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA-sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.

North America dominated the NGS-based RNA-sequencing market

North America accounted for the largest share of the market in 2018. The large share of this region is the growing prevalence of target diseases, government support through funds for genomics research, advancements in RNA-Seq products, increasing research on cancer & inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US) in this region.

Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. among others are the major players operating in the NGS-based RNA-sequencing market.